Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes
Jacqueline Ramírez; Federico Innocenti; Erin G. Schuetz; David A. Flockhart; Mary V. Relling; Raymond Santucci; Mark J. Ratain (Profiled Author: David A. Flockhart)
Drug Metabolism and Disposition. 2004;32(9):930-936.Abstract
Meperidine is an opioid analgesic metabolized in the liver by N-demethylation to normeperidine, a potent stimulant of the central nervous system. The purpose of this study was to identify the human cytochrome P450 (P450) enzymes involved in normeperidine formation. Our in vitro studies included 1) screening 16 expressed P450s for normeperidine formation, 2) kinetic experiments on human liver microsomes and candidate P450s, and 3) correlation and inhibition experiments using human hepatic microsomes. After normalization by its relative abundance in human liver microsomes, CYP2B6, CYP3A4, and CYP2C19 accounted for 57, 28, and 15% of the total intrinsic clearance of meperidine. CYP3A5 and CYP2D6 contributed to < 1%. Formation of normeperidine signifi cantly correlated with CYP2B6-selective S-mephenytoin N-demethylation (r = 0.88, p < 0.0001 at 75 μM meperidine, and r = 0.89, p α 0.0001 at 350 μM meperidine, n = 21) and CYP3A4-selective midazolam 1'-hydroxylation (r = 0.59, p < 0.01 at 75 μM meperidine, and r = 0.55, p < 0.01 at 350 μM meperidine, n = 23). No significant correlation was observed with CYP2C19-selective S-mephenytoin 4'hydroxylation (r = 0.36, p = 0.2 at 75 μM meperidine, and r = 0.02, p = 0.9 at 350 μM meperidine, n = 13). An anti-CYP2B6 antibody inhibited normeperidine formation by 46%. In contrast, antibodies inhibitory to CYP3A4 and CYP2C8/9/18/19 had little effect (< 14% inhibition). Experiments with thiotepa and ketoconazole suggested inhibition of microsomal CYP2B6 and CYP3A4 activity, whereas studies with fluvoxamine (a substrate of CYP2C19) were inconclusive due to lack of specificity. We conclude that normeperidine formation in human liver microsomes is mainly catalyzed by CYP2B6 and CYP3A4, with a minor contribution from CYP2C19.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
J.C. Gorski; D.R. Jones; S.A. Wrighton; S.D. HallXenobiotica. 1997;27(3):243-256.
J.C. Gorski; D.R. Jones; M.A. Hamman; S.A. Wrighton; S.D. HallXenobiotica. 1999;29(9):931-944.
James M. Rae; Nadia V. Soukhova; David A. Flockhart; Zeruesenay DestaDrug Metabolism and Disposition. 2002;30(5):525-530.
Appears in this Document